Merck seeks US authorisation for pill to treat COVID
Al Jazeera
US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases.
US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus.
Merck submitted the application for molnupiravir, which it said earlier this month was shown to reduce coronavirus hospitalisations by 50 percent in early trials, to the US Food and Drug Administration (FDA) on Monday.
Merck, which is called MSD outside the United States and Canada, said it was working “with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months”.
UN health agency says its decision is ‘based on the rising number and continuing geographic spread of cases.’
In a new interview, the scandal-plagued Gaetz reaffirmed his commitment to being a member of Trump’s ‘America First army’.
Legislators greenlight reforms giving more authority to Daniel Ortega and Rosario Murillo, accused of stifling dissent.
Pep Guardiola leads Man City out for the first time since signing a two-year extension when Tottenham visit on Saturday.
Five healthcare workers killed in Israeli strikes in southern Lebanon, Ministry of Public Health says.
Vulnerable nations are seeking $1.3 trillion annually to deal with the damage caused by climate change and to adapt.
The city’s southern suburbs have been hit repeatedly in recent months
New York judge cancels a sentencing hearing previously scheduled for November 26 without setting a new date.
Many Haitian children face the stark choice of joining a gang or suffering from violence, poverty and hunger engulfing them.
Tapped to lead the Justice Department, Bondi is a former Florida attorney general and longtime Trump supporter.
The arrest warrants against Netanyahu and Gallant could lead to countries rethinking arms deals with Israel, experts say